Brokerages Anticipate Medidata Solutions (MDSO) Will Announce Earnings of $0.40 Per Share
Brokerages expect Medidata Solutions (NASDAQ:MDSO) to announce $0.40 earnings per share for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Medidata Solutions’ earnings, with the highest EPS estimate coming in at $0.42 and the lowest estimate coming in at $0.39. Medidata Solutions posted earnings of $0.31 per share in the same quarter last year, which suggests a positive year-over-year growth rate of 29%. The business is scheduled to issue its next earnings results on Tuesday, July 17th.
According to Zacks, analysts expect that Medidata Solutions will report full-year earnings of $1.72 per share for the current fiscal year, with EPS estimates ranging from $1.67 to $1.76. For the next fiscal year, analysts forecast that the company will report earnings of $2.10 per share, with EPS estimates ranging from $1.94 to $2.25. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research firms that follow Medidata Solutions.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings data on Thursday, April 19th. The company reported $0.40 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.05. Medidata Solutions had a return on equity of 11.36% and a net margin of 7.96%. The business had revenue of $149.20 million for the quarter, compared to the consensus estimate of $146.73 million. During the same period last year, the business earned $0.31 EPS. The firm’s revenue was up 16.9% compared to the same quarter last year.
In other Medidata Solutions news, CEO Tarek Sherif sold 26,836 shares of Medidata Solutions stock in a transaction that occurred on Monday, March 12th. The stock was sold at an average price of $70.25, for a total value of $1,885,229.00. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Rouven Bergmann sold 2,000 shares of Medidata Solutions stock in a transaction that occurred on Monday, March 19th. The stock was sold at an average price of $66.30, for a total value of $132,600.00. Following the completion of the transaction, the chief financial officer now directly owns 94,744 shares in the company, valued at $6,281,527.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 46,231 shares of company stock worth $3,258,559. Company insiders own 4.70% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Clearbridge Investments LLC grew its holdings in shares of Medidata Solutions by 0.4% during the 4th quarter. Clearbridge Investments LLC now owns 2,171,755 shares of the company’s stock worth $137,624,000 after purchasing an additional 9,425 shares in the last quarter. Champlain Investment Partners LLC grew its holdings in shares of Medidata Solutions by 15.7% during the 1st quarter. Champlain Investment Partners LLC now owns 2,148,615 shares of the company’s stock worth $134,955,000 after purchasing an additional 291,630 shares in the last quarter. American Century Companies Inc. grew its holdings in shares of Medidata Solutions by 0.3% during the 1st quarter. American Century Companies Inc. now owns 1,444,426 shares of the company’s stock worth $90,724,000 after purchasing an additional 4,716 shares in the last quarter. Global Thematic Partners LLC grew its holdings in shares of Medidata Solutions by 37.3% during the 4th quarter. Global Thematic Partners LLC now owns 1,429,138 shares of the company’s stock worth $90,564,000 after purchasing an additional 388,608 shares in the last quarter. Finally, Disciplined Growth Investors Inc. MN grew its holdings in shares of Medidata Solutions by 12.2% during the 1st quarter. Disciplined Growth Investors Inc. MN now owns 932,254 shares of the company’s stock worth $58,555,000 after purchasing an additional 101,398 shares in the last quarter.
Shares of Medidata Solutions traded down $0.76, reaching $75.33, during trading on Friday, MarketBeat.com reports. The company had a trading volume of 425,356 shares, compared to its average volume of 652,970. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.63 and a current ratio of 1.63. Medidata Solutions has a one year low of $59.60 and a one year high of $85.92. The company has a market capitalization of $4.46 billion, a price-to-earnings ratio of 88.62, a PEG ratio of 3.78 and a beta of 1.49.
About Medidata Solutions
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.